This report, The changing nature of diagnosis, sets out the implications for practitioners and patients of the technological revolution in diagnosis. The report includes three priorities for action ...

Heather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a ...

The rise of at-home health “self tests” promises user empowerment, convenience, and early detection all wrapped up in slick ...

This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn had the opportunity to comment for radio coverage of the ...

In a world first, the NHS has announced it is rolling out ‘blood-test first’ testing for patients with non-small cell lung cancer (NSCLC) in England. The tests have been added to the Genomic Test ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

The GenomeIndia Project is working to close the genomic data diversity gap and opening its genetic database to researchers worldwide ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...